Loading Events

« All Events

The 37th Annual EAU Congress

July 1 - July 4

Friday 1st of July 

07.45 – 08.00 Game Changing session 2  The real effect of prostate cancer treatment: EUPROMS 2.0 study patient driven quality of life study follow-up in order to answer questions following EUPROMS 1.0  A. Deschamps, Antwerp (BE)
Location: Grey Area, eURO Auditorium 2

12:15 – 13:45: session: New technologies and urological applications – Chair: C.H. Bangma, Rotterdam (NL)
Location: Grey Area, eURO Auditorium 2
12:33 – 12:43 Presentation PDOs and chemoresistance in BC session – T. Zuiverloon, Rotterdam (NL)

10:30 – 13:30 Prostate cancer early detection: What men need to know
Location: Orange Area, eURO Auditorium 1
Chairs:  P. Albers, Düsseldorf (DE)  A. Deschamps, Antwerp (BE) –  M.J. Roobol, Rotterdam (NL)
10:45 – 11:00 ERSPC update plus long FU Cohorts –  M.J. Roobol, Rotterdam (NL)
11:15 – 11:30 We have the way out! Risk calculators and algorithm  – R. Hogenhout, Rotterdam (NL)

10:45 – 12:15 Abstract Session 05: NMIBC – BCG, urinary markers, therapeutic pathways and mechanisms of action.
Location: Yellow Area, Room Forum
Non-muscle invasive bladder cancer subtypes with differential response to intravesical bacillus Calmette-Guerin treatment – C. de Jong, Rotterdam (NL)

14:00 – 16:00 Active surveillance for intermediate risk prostate cancer: What urologist and patients should know
Location: Grey Area, eURO Auditorium 2
14:10 – 14:20 Less overdiagnosis of low risk PCa means mainly intermediate risks for AS: Dream or reality –  M.J. Roobol, Rotterdam (NL)

Saturday 2nd of July 

10.35 – 10.45: State-of-the-art lectures ESAU meeting (EAU section meeting andrological urology) – Chair: M. Dinkelman, Rotterdam (NL)
Location: Purple Area, Room Elicium 1

10.45 – 12.15 uur – Session 15: Active surveillance and modern diagnostics
Location: Yellow Area, Room Forum
QoL for higher vs. lower educated men following AS, RP or RT in the patient-initiated EUPROMS study – L. Venderbos, Rotterdam (NL)
Active surveillance for prostate cancer: uptake over time and the impact of an organized protocol – S. Remmers, Rotterdam (NL)
External validation of a model predicting increase in Gleason grade for men on Active Surveillance in the GAP3 consortium database – D. Nieboer, Rotterdam (NL)

10:45 – 13:45 Rapid-fire debates: Common problems in bladder cancer. J. Boormans, Rotterdam (NL)
Location: Grey Area, eURO Auditorium 2

10:30 – 13:50 Biomarkers in uro-oncology: From bench to bedside. Joint meeting of the EAU Section of Uropathology (ESUP) and the EAU Section of Urological Research (ESUR)
Location: Green Area, Room 5
10:35 – 11:40 Emerging role of RNA modifications in tumor biology of urological carcinomas for new therapeutic strategies and biomarker development
Moderators: E.S. Martens-Uzunova, Rotterdam (NL), A. Hartmann, Erlangen (DE)
10:35 – 10:50 The RNA modification network,  E.S. Martens-Uzunova, Rotterdam (NL)

15:00 – 16:30 Prostate cancer screening and early detection – Reloaded! Abstract Session 20
Location: Orange Area, Room 2
Chairs  F. Abdollah, Detroit (US)  B.A. Hadaschik, Essen (DE)  M.J. Roobol, Rotterdam (NL)
15:00 – 15:03 Introduction The difference between early detection and screening – What we need to know and change as urologists  – M.J. Roobol, Rotterdam (NL)
15:14 – 15:21 Baseline PSA below 1.0 ng/ml, and then? Verification of the EAU 2021 Position and Recommendation on risk-adapted early detection using ERSPC Rotterdam data with more than 20 years of detailed follow-up – M.J. Roobol, Rotterdam (NL)
Twenty-year outcome of men participating in a screening trial with an initial negative prostate biopsy – I. de Vos, Rotterdam (NL)
How long do men stay in intermediate stages between randomization and death: results of ERSPC Rotterdam – S. Remmers, Rotterdam (NL)
Shifting risk-stratified early detection of prostate cancer to primary health care – R. Hogenhout, Rotterdam (NL)

18:30 – 20:00 Industry Session Janssen: Practical considerations for early-stage bladder cancer: case-based discussions for managing patients with NMIBC and MIBC (HYBRID). J. Boormans, Rotterdam (NL)

Sunday 3th of July 

10:30 – 12:00 Thematic Session 03: Testis cancer: Pushing boundaries in diagnosis and treatment. J. Boormans, Rotterdam (NL)
Location: Green Area, Room 1
11.04 –   case presentation testiscarcinoom – T. Zuiverloon, Rotterdam (NL)

12.15 – 13.45 uur – Session 33: Prostate biopsies: which route, which complications, which pathological results?
Location: Orange area room 2
Prostate cancer detection rate of transrectal versus transperineal MRI-TRUS fusion prostate biopsy: experience in 794 cases – R. Hogenhout, Rotterdam (NL)
Complications after transrectal prostate biopsy with antibiotic prophylaxis versus transperineal without antibiotic prophylaxis: comparison of two clinical practices – R. Hogenhout, Rotterdam (NL)

12:15 – 13:45 PIONEER real-world evidence, big data and prostate cancer European public-private research network funding through the IMI
Location: Green Area, Room 1
13:30 – 13:40 Real-world evidence implementation in guidelines development, is the data quality there?  M.J. Roobol, Rotterdam (NL)

12:15 – 13:45 Abstract Session 30: Testicular cancer – Tailoring treatments to reduce toxicities – Chair J.  Boormans, Rotterdam (NL)
Location: Green Area, Room 5

14.00 – 15.30 Session 40: Prostate biopsy indication and strategy: Which role for which imaging by MRI, PET, US.
Location: orange area, room 2
A comparison of the PLUM and RPCRC- MRI-based prostate cancer risk prediction models in two North American and European cohorts – S. Remmers, Rotterdam (NL)

15:45 – 17:15 Abstract Session 48: Advanced bladder cancer: Staging, predicting factors and systemic therapy.
Location: Yellow Area, Room Forum
A genomic urine assay to detect urinary tract recurrences in patients with bladder cancer treated with radiotherapy – C. de Jong, Rotterdam (NL)

Monday 4th of July 

08:00 – 10:15 Plenary Session 07: Liquid biomarkers in 2022 and beyond: Ready for prime time? J. Boormans, Rotterdam (NL)
Location: Orange Area, eURO Auditorium 1

08.30 – 10.30 ESU course 45: the infertile couple; urological aspects. Chair M. Dinkelman, Rotterdam (NL) 
Location: Grey Area, Room G104
2 ESU courses (varicocele and refertilisation)

10:30 – 12:00 Liquid- and tumour biomarkers in prostate cancer Abstract Session 50
Location: Green Area, Room 3
Chairs G.M. Carbone, Bellinzona (CH), C. Jeronimo, Porto (PT) and W.M. Van Weerden, Rotterdam (NL)
10:30 – 11:00 Post-plenary discussion ‘Liquid biomarkers in 2022 and beyond: Ready for prime time?’: Meet the experts. J. Boormans, Rotterdam (NL)

10:30 – 12:00 Best EAU22 abstracts selected by the Scientific Committee
11:17 – 11:22 Paediatrics –  L. ‘t Hoen, Rotterdam (NL)

12:15 – 13:45 Session: advanced urothelial cancer – organoids, response mechanisms and biomarkers. Chair T. Zuiverloon, Rotterdam (NL)

*12.15 – 13.45 uur – Session 60: Improving functional outcome of prostatectomy.
Continence after introducing NeuroSAFE in radical prostatectomy – M. van der Slot, Rotterdam (NL)  (S. Remmers, M. Robool & L. Venderbos)
*14.00 – 15.30 uur – Session 62: Surgical management and quality outcome in prostate cancer treatment.
Identification of pathologic factors associated with intraoperative positive surgical margins at NeuroSAFE for clinical decision-making on nerve-sparing surgery– M. van der Slot, Rotterdam (NL)

14:00-15:30 Androgen receptor and cellular plasticity in prostate cancer: How to improve therapies
Location: Green Area, Room 2
Chairs Z. Culig, Innsbruck (AT) and W.M. Van Weerden, Rotterdam (NL)
14:00 – 14:15 Androgen receptor targeting to improve taxane efficacy. S. Buck & W.M. van Weerden, Rotterdam (NL)

14.00 – 15.30 Thematic session genetics male reproductive potential
15.10-15.20 The impact of paternal age on natural male fertility potential and on the outcome of ART – M. Dinkelman, Rotterdam (NL)

15:45 – 17:45 EAU Specialty Session: Best of EAU22 session
16:40 – 16:50 Bladder cancer, J. Boormans
16:50 – 17:00 Upper Tract TCC, J. Boormans
17:00 – 17:10 Paediatrics, L. ‘t Hoen
17:20 – 17:30 Andrology. M. Dinkelman


July 1
July 4




RAI Amsterdam
Netherlands + Google Map